The following is a summary of “An Updated Review of Immune Checkpoint Inhibitors in Cutaneous Oncology: Beyond Melanoma,” ...
It is considered a precursor to non-melanoma skin cancers, particularly cutaneous squamous cell carcinoma (cSCC). Given the increasing prevalence of AK, especially among older adults, effective ...
A new case-control study explores the potential protective effects of metformin against non-melanoma skin cancers, including ...
Learn how melanoma impacts African Americans, highlighting detection challenges, survival disparities, and prevention ...
Metformin, a widely prescribed medication for type 2 diabetes, may help protect individuals from the 2 most common types of ...
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...
The future of skin cancer treatment looks even more promising. Advances in artificial intelligence (AI) are revolutionizing ...
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a new review article has been published highlighting ...
Metformin, widely prescribed for type 2 diabetes, may also protect against the two most common types of skin cancer.
A recent study suggests that metformin, a widely prescribed medication for type 2 diabetes, may reduce the risk of developing ...